GlassScriptPhysician profile
James Mcgovern
NPI 1699368092
$4,363.19
in general payments reported to CMS, 2019-2025
17 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $577 · 2022: $994 · 2023: $2,067 · 2024: $337 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,387 · Food and Beverage: $1,340 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,386.67 |
| Food and Beverage | $1,340.02 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,885.95 | 2022-2025 | Aquabeam Robotic System |
| Medtronic, INC. | $471.10 | 2021-2025 | Interstim |
| Teleflex LLC | $373.18 | 2021-2024 | Urolift |
| Astrazeneca Pharmaceuticals LP | $349.45 | 2021-2023 | Lynparza |
| Astellas Pharma US INC | $309.75 | 2021-2023 | Myrbetriq, Veozah |
| Janssen Biotech, INC. | $243.21 | 2022-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $202.07 | 2021-2025 | |
| Boston Scientific Corporation | $111.04 | 2021 | |
| Olympus America INC. | $89.25 | 2021-2023 | Soltive |
| Blue Earth Diagnostics | $69.29 | 2022 | |
| Myriad Genetic Laboratories, INC. | $62.50 | 2022-2024 | Prolaris |
| Pfizer INC. | $58.98 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $37.87 | 2023 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $36.71 | 2021-2023 | Provenge |
| Regeneron Healthcare Solutions, INC. | $31.30 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $17.29 | 2022 | |
| Antares Pharma, INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcgovern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.